Emerging Cancer Vaccines: Market Forecasts, New Developments And Pipeline Analysis, 3rd Edition

Emerging Cancer Vaccines: Market Forecasts, New Developments and Pipeline Analysis

, 3rd Edition

Pages : 250

It is the general consensus of scientists that cancer vaccines will become a reality. Overall the cancer treatment market continues to grow and this demand sets the stage for vaccine products.

Several promising vaccines: the propholactic Gardasil has created a pathway for new vaccine products. M-Vax, Ocon-Vax in late stage development and are preparing for regulatory review in the United States, Europe, Canada, or other international regions. Many of the products with potential approval status over the coming years are already in Phase III development, have orphan drug status, SPA status, or Fast Track status. This provides a promising future for many of these products. Additionally, some products in international regions have been granted compassionate use status which is significant in evaluating need on a patient-by-patient basis. In this report, Kalorama Information provides a realistic estimate of the cancer vaccine for the near term for the following products:

Melonoma Vaccines

Lung Cancer Vaccines

Prostate Cancer Vaccines

Cervical Cancer Vaccines

Brain Cancer Vaccines

Colon/Rectal Cancer Vaccines

Breast Cancer Vaccines

Lymphoma Vaccines

Ovarian Cancer Vaccines

Leukemia Vaccines

Bladder Cancer Vaccines

As part of its exhaustive research and analysis, this report provides:

Forecasts for Future Revenues from Cancer Vaccines

Cancer Epidemiology

Reviews of Products in the Pipeline

Detailed Profiles of 13 Companies Operating in the Cancer Vaccine Market

Directory of Related Companies

Some of the issues discussed in this report important for anyone operating in this market include:

Introduction

Early Detection and Screening

Monoclonal Antibodies and Therapeutic Vaccines

Political and Social Pressure

Insurance and Reimbursement Issues

Personalized Medicine

Pharmacogenomics

Vaccine Strategies

New Genetic Technique

Future Growth in Vaccines

As part of its detailed coverage of developments in cancer vaccines..the following companies are profiled in this report:

Antigenics, Inc.

Avax Technologies, Inc.

Biovest International, Inc.

Cell Genesys, Inc.

Dendreon Corporation

Genitope Corporation

GlaxoSmithKline plc

Merck & Company, Inc.

Northwest Biotherapeutics, Inc.

NovaRx

Oncothyreon

Vaccinogen

Vical, Inc.

For more information please visit :

http://www.aarkstore.com/reports/Emerging-Cancer-Vaccines-Market-Forecasts-New-Developments-and-Pipeline-Analysis-3rd-Edition-12907.html

From: Aarkstore Enterprise

Contact: Anna

Ph.No.91927282585

Email: winaarkstore@gmail.com

URL:http://www.aarkstore.com/

by: Aarkstore Enterprise

POST COMMENT

Leather Sofas A New Trend Of Sofas The Features Of New Credit Card Wallets Revolutionary New Origami-style Card Teaches Children Their Abcs Iskysoft Releases Discounted Dvd Copy Pro For Mac For 2011 New Year Holiday Special Offer Install a composite front door to comply with new building regulations Fashion Guilty Ideas For A New Year's Eve Party The Lunar Chinese New Year - A Completely Different Celebration Tips On How To Add New Product To Your OsCommerce Internet Shop Swiftly And Simply Do Not Think Hiring A Moving Company Is A Waste Of Money! What is indoor lighting all about? Make First Day Of New Year Rocking With Dish Network Victoria Parking Barcelona has announced the grand opening of its new parking facilities at El Prat airport for the 16 December New Mobile Phones 2011 New Year With The New Range Of Mobile Phones